Cargando…
Controlled delivery of a protein tyrosine phosphatase inhibitor, SHP099, using cyclodextrin-mediated host–guest interactions in polyelectrolyte multilayer films for cancer therapy
The Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) is a key enzyme in pathways regulating tumor growth signaling, and recently gained interest as a promising anticancer drug target. Many SHP2 inhibitors are currently under development, including SHP099, which has shown potent...
Autores principales: | Wang, Soobin, Battigelli, Alessia, Alkekhia, Dahlia, Fairman, Alexis, Antoci, Valentin, Yang, Wentian, Moore, Douglas, Shukla, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054207/ https://www.ncbi.nlm.nih.gov/pubmed/35520441 http://dx.doi.org/10.1039/d0ra03864d |
Ejemplares similares
-
Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018) -
Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect
por: Sun, Ziying, et al.
Publicado: (2022) -
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
por: Markovics, Adrienn, et al.
Publicado: (2020) -
Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase
Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022) -
Determination of the molecular reach of the protein tyrosine phosphatase SHP-1
por: Clemens, Lara, et al.
Publicado: (2021)